Cargando…
Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies
Chronic infection with hepatitis B virus (HBV) represents one of the main causes of the development of cirrhosis and its complications. Treatment with potent third-generation nucleos(t)ide analogues (NUCs) results in >99% HBV DNA undetectability, and prevents fibrosis progression and liver-relate...
Autores principales: | Degasperi, Elisabetta, Anolli, Maria Paola, Lampertico, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699048/ https://www.ncbi.nlm.nih.gov/pubmed/36366502 http://dx.doi.org/10.3390/v14112404 |
Ejemplares similares
-
Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
por: Lampertico, Pietro, et al.
Publicado: (2023) -
How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?
por: Loglio, Alessandro, et al.
Publicado: (2020) -
Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
por: D’Ambrosio, Roberta, et al.
Publicado: (2021) -
The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest Insights
por: Fabrizi, Fabrizio, et al.
Publicado: (2023) -
Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)